Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Organized breast cancer screening programs in Canada

¹Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany. A.Miller@DKFZ-Heidelberg.de

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne

|November 18, 2000

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of blue light therapy on plasma adrenocorticotropic hormone (ACTH) and hypertrichosis in horses with pituitary pars intermedia dysfunction.

Domestic animal endocrinology·2021

Same author

Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses.

Domestic animal endocrinology·2020

Same author

Reply to Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use?

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

The role of screening mammography in the era of modern breast cancer treatment.

Climacteric : the journal of the International Menopause Society·2018

Same author

The OncoSim model: development and use for better decision-making in Canadian cancer control.

Current oncology (Toronto, Ont.)·2017

Same author

Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.

Current oncology (Toronto, Ont.)·2016